What does CUSIP 67079U306 represent in this 13F holders report?

CUSIP 67079U306 is the security identifier for NUTX - Nutex Health Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

How many institutions held NUTX - Nutex Health Inc. - Common Stock, $0.001 par value in Q2 2025?

101 institutional investors reported NUTX - Nutex Health Inc. - Common Stock, $0.001 par value for Q2 2025. Use the holders table for investor-level position and value details.

Nutex Health Inc. - Common Stock, $0.001 par value (NUTX)

CUSIP: 67079U306

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 6,864,898
Total 13F shares: 1,744,372
Share change: +730,362
Total reported value: $217,157,205
Price per share: $124.49
Number of holders: 101
Value change: +$94,889,528
Number of buys: 78
Number of sells: 23

Quarterly Holders Quick Answers

What is CUSIP 67079U306?
CUSIP 67079U306 identifies NUTX - Nutex Health Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 67079U306:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NUTX - Nutex Health Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Micro Hospital Holding LLC	3/4/5	10%+ Owner	— class O/S missing	267,728,389	$60,506,616	—	01 Apr 2022	3/4/5
Matthew Stephen Young	3/4/5	Director	— class O/S missing	42,134,210	$9,522,331	—	01 Apr 2022	3/4/5
Topline Capital Management, LLC	13F	Company	2.6%	179,713	$8,451,902	—	31 Mar 2025	13F
VANGUARD GROUP INC	13F	Company	2%	134,811	$6,340,161	—	31 Mar 2025	13F
ESSEX INVESTMENT MANAGEMENT CO LLC	13F	Company	1.3%	87,223	$4,102,098	—	31 Mar 2025	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	1.1%	74,359	$3,497,104	—	31 Mar 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.88%	60,696	$2,854,533	—	31 Mar 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.75%	51,500	$2,422,045	—	31 Mar 2025	13F
ONE PLUS ONE WEALTH MANAGEMENT, LLC	13F	Company	0.55%	37,541	$1,765,553	—	31 Mar 2025	13F
BlackRock, Inc.	13F	Company	0.54%	37,008	$1,740,486	—	31 Mar 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.53%	36,375	$1,711,521	—	31 Mar 2025	13F
TRUIST FINANCIAL CORP	13F	Company	0.46%	31,570	$1,484,737	—	31 Mar 2025	13F
Dominis-Embree AHA Investor, LLC	3/4/5	10%+ Owner	— class O/S missing	6,473,483	$1,463,007	—	26 Feb 2021	3/4/5
Legato Capital Management LLC	13F	Company	0.38%	25,861	$1,216,243	—	31 Mar 2025	13F
Dr. Danniel Stites	3/4/5	Director	— class O/S missing	5,355,375	$1,210,315	—	01 Apr 2023	3/4/5
Joshua DeTillio	3/4/5	Chief Operating Officer	— mixed-class rows	16,681 mixed-class rows	$1,202,653	—	01 Mar 2025	3/4/5
DRIVE WEALTH MANAGEMENT, LLC	13F	Company	0.34%	23,363	$1,098,762	—	31 Mar 2025	13F
MARSHALL WACE, LLP	13F	Company	0.32%	21,814	$1,025,913	—	31 Mar 2025	13F
Robert Chan	3/4/5	Director	— class O/S missing	4,389,691	$992,070	—	25 Feb 2021	3/4/5
Informed Momentum Co LLC	13F	Company	0.27%	18,457	$868,033	—	31 Mar 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.26%	18,119	$852,137	—	31 Mar 2025	13F
Ancora Advisors LLC	13F	Company	0.26%	18,086	$850,585	—	31 Mar 2025	13F
Russell Investments Group, Ltd.	13F	Company	0.22%	15,107	$710,521	—	31 Mar 2025	13F
STATE STREET CORP	13F	Company	0.2%	13,957	$656,398	—	31 Mar 2025	13F
AVANTAX ADVISORY SERVICES, INC.	13F	Company	0.18%	12,267	$576,917	—	31 Mar 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.16%	11,100	$522,033	—	31 Mar 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.16%	10,756	$505,855	—	31 Mar 2025	13F
Baader Bank Aktiengesellschaft	13F	Company	0.16%	10,700	$503,221	—	31 Mar 2025	13F
Squarepoint Ops LLC	13F	Company	0.14%	9,934	$467,196	—	31 Mar 2025	13F
OMERS ADMINISTRATION Corp	13F	Company	0.14%	9,400	$442,082	—	31 Mar 2025	13F
HRT FINANCIAL LP	13F	Company	0.13%	8,593	$404,000	—	31 Mar 2025	13F
Scissortail Wealth Management, LLC	13F	Company	0.12%	8,220	$386,587	—	31 Mar 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.1%	7,046	$331,373	—	31 Mar 2025	13F
NORTHERN TRUST CORP	13F	Company	0.1%	6,996	$329,022	—	31 Mar 2025	13F
World Investment Advisors	13F	Company	0.1%	6,852	$322,250	—	31 Mar 2025	13F
Mark Fawcett	3/4/5	Director	— mixed-class rows	365,977 mixed-class rows	$296,741	—	25 Feb 2021	3/4/5
Tidal Investments LLC	13F	Company	0.07%	4,646	$218,501	—	31 Mar 2025	13F
Creative Planning	13F	Company	0.07%	4,511	$212,152	—	31 Mar 2025	13F
UBS Group AG	13F	Company	0.06%	4,333	$203,781	—	31 Mar 2025	13F
MAI Capital Management	13F	Company	0.05%	3,697	$173,870	—	31 Mar 2025	13F
Anh Nguyen	3/4/5	President of subsidiary	— class O/S missing	683,134	$154,388	—	01 Oct 2021	3/4/5
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	2,504	$117,763	—	31 Mar 2025	13F
CITIGROUP INC	13F	Company	0.03%	2,124	$99,892	—	31 Mar 2025	13F
Michael Bowen	3/4/5	Retired CFO	— class O/S missing	437,105	$98,786	—	14 Sep 2022	3/4/5
MORGAN STANLEY	13F	Company	0.03%	1,874	$88,134	—	31 Mar 2025	13F
Lawrence Schimmel	3/4/5	Chief Medical Information Off	— class O/S missing	263,444	$59,538	—	02 Apr 2022	3/4/5
John J. Waters	3/4/5	Director	— class O/S missing	196,262	$44,355	—	18 May 2023	3/4/5
WealthCollab, LLC	13F	Company	0.01%	845	$39,741	—	31 Mar 2025	13F
Beaird Harris Wealth Management, LLC	13F	Company	0.01%	700	$32,921	—	31 Mar 2025	13F
Mitchell Creem	3/4/5	Director	— class O/S missing	81,746	$18,475	—	14 Jun 2023	3/4/5

Institutional Holders of Nutex Health Inc. - Common Stock, $0.001 par value (NUTX) as of Q2 2025

As of 30 Jun 2025, Nutex Health Inc. - Common Stock, $0.001 par value (NUTX) was held by 101 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,744,372 shares. The largest 10 holders included Topline Capital Management, LLC, BlackRock, Inc., VANGUARD GROUP INC, AMERICAN CENTURY COMPANIES INC, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Divisadero Street Capital Management, LP, UBS Group AG, and ONE PLUS ONE WEALTH MANAGEMENT, LLC. This page lists 101 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

101

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.